809 related articles for article (PubMed ID: 16797734)
41. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
Sergerie Y; Boivin G
Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252
[TBL] [Abstract][Full Text] [Related]
42. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
43. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Wilber BA; Docherty JJ
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
[TBL] [Abstract][Full Text] [Related]
44. Three-dimensional analysis of combination effect of ellagitannins and acyclovir on herpes simplex virus types 1 and 2.
Vilhelmova N; Jacquet R; Quideau S; Stoyanova A; Galabov AS
Antiviral Res; 2011 Feb; 89(2):174-81. PubMed ID: 21134403
[TBL] [Abstract][Full Text] [Related]
45. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene.
Morfin F; Thouvenot D; Aymard M; Souillet G
J Med Virol; 2000 Oct; 62(2):247-50. PubMed ID: 11002255
[TBL] [Abstract][Full Text] [Related]
46. Resistance of herpes simplex virus type 1 to acyclovir: thymidine kinase gene mutagenesis study.
Frobert E; Ooka T; Cortay JC; Lina B; Thouvenot D; Morfin F
Antiviral Res; 2007 Feb; 73(2):147-50. PubMed ID: 16970995
[TBL] [Abstract][Full Text] [Related]
47. Melissa officinalis oil affects infectivity of enveloped herpesviruses.
Schnitzler P; Schuhmacher A; Astani A; Reichling J
Phytomedicine; 2008 Sep; 15(9):734-40. PubMed ID: 18693101
[TBL] [Abstract][Full Text] [Related]
48. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
[TBL] [Abstract][Full Text] [Related]
49. [Antiviral resistance of herpes simplex virus and varicella-zoster virus].
Daikoku T; Shiraki K
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():480-6. PubMed ID: 17455667
[No Abstract] [Full Text] [Related]
50. Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization.
Fillet AM; Dumont B; Caumes E; Visse B; Agut H; Bricaire F; Huraux JM
J Med Virol; 1998 Jul; 55(3):250-4. PubMed ID: 9624615
[TBL] [Abstract][Full Text] [Related]
51. Antiviral activity of Rhus aromatica (fragrant sumac) extract against two types of herpes simplex viruses in cell culture.
Reichling J; Neuner A; Sharaf M; Harkenthal M; Schnitzler P
Pharmazie; 2009 Aug; 64(8):538-41. PubMed ID: 19746844
[TBL] [Abstract][Full Text] [Related]
52. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
53. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
[TBL] [Abstract][Full Text] [Related]
54. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
Sauerbrei A; Deinhardt S; Zell R; Wutzler P
Antiviral Res; 2010 Jun; 86(3):246-52. PubMed ID: 20211650
[TBL] [Abstract][Full Text] [Related]
55. Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.
Suzutani T; Saijo M; Nagamine M; Ogasawara M; Azuma M
J Clin Microbiol; 2000 May; 38(5):1839-44. PubMed ID: 10790110
[TBL] [Abstract][Full Text] [Related]
56. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
[TBL] [Abstract][Full Text] [Related]
57. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.
Duan R; de Vries RD; van Dun JM; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2009 Nov; 200(9):1402-14. PubMed ID: 19795980
[TBL] [Abstract][Full Text] [Related]
58. Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues.
Weinberg A; Leary JJ; Sarisky RT; Levin MJ
J Clin Virol; 2007 Feb; 38(2):139-45. PubMed ID: 17169605
[TBL] [Abstract][Full Text] [Related]
59. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
Varadinova T; Vilhelmova N; Badenas F; TerrĂ³n A; Fiol J; Garcia-Raso A; Genova P
Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]